Article
Characterization of the P140K, PVP(138-140)MLK, and G156A O6-methylguanine-DNA methyltransferase mutants: implications for drug resistance gene therapy.
Human gene therapy - 20 Nov 1999
Davis B M, Roth J C, Liu L, Xu-Welliver M, Pegg A E, Gerson S L
Abstract excerpt
The G156A O6-alkylguanine-DNA alkyltransferase (AGT) mutant protein, encoded by the G156A O6-methylguanine-DNA methyltransferase gene (MGMT), is resistant to O6-benzylguanine (BG) inactivation and, after transduction into hematopoietic progenitors, transmits remarkable resistance to BG and BCNU. As a result, a clinical trial, in which the MGMT gene is transduced into CD34+ cells of patients with cancer, has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
